EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Trends and antimicrobial resistance of pathogens causing bloodstream infections among febrile neutropenic adults with hematological malignancy



Trends and antimicrobial resistance of pathogens causing bloodstream infections among febrile neutropenic adults with hematological malignancy



Journal of the Formosan Medical Association 103(7): 526-532



Background and Purposes: The microbiological spectrum in cancer patients with febrile neutropenia has changed over the past several decades in western countries. The growing incidence of antimicrobial resistance is an inevitable consequence of the widespread use of antibiotics in medical settings. The aim of this study was to clarify the trends and antimicrobial resistance among pathogens causing blodstream infections in febrile neutropenic adults with hematological malignancies.

(PDF emailed within 1 workday: $29.90)

Accession: 012710661

Download citation: RISBibTeXText

PMID: 15318274



Related references

Antimicrobial resistance in pathogens causing nosocomial bloodstream infections in university hospitals in Egypt. American Journal of Infection Control 39(9): E61-E65, 2012

Bloodstream infections in febrile neutropenic patients: bacterial spectrum and antimicrobial susceptibility pattern. Journal of Ayub Medical College, Abbottabad 16(1): 18-22, 2004

Trends in spectrum and susceptibility patterns of pathogens causing bacteremia in pediatric febrile neutropenic oncologic patients. International Journal of Infectious Diseases 6(Supplement 2): 2S28-2S31, June, 2002

Epidemiology and antimicrobial susceptibility profiles of pathogens causing urinary tract infections in the Asia-Pacific region: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2010-2013. International Journal of Antimicrobial Agents 47(4): 328-334, 2016

Prevalence of multidrug-resistant Gram-negative pathogens isolated from febrile neutropenic cancer patients with bloodstream infections in Egypt and new synergistic antibiotic combinations. Infection and Drug Resistance 11: 791-803, 2018

Bloodstream infections in neutropenic patients: early detection of pathogens and directed antimicrobial therapy due to surveillance blood cultures. Annals of Oncology 18(11): 1870-1874, 2007

Bloodstream infections in febrile neutropenic patients at a tertiary cancer institute in South India: A timeline of clinical and microbial trends through the years. Indian Journal of Medical and Paediatric Oncology 37(3): 174-182, 2016

Secondary Infections in Febrile Neutropenia in Hematological Malignancies: More Than Another Febrile Neutropenic Episode. Turkish Journal of Haematology 32(3): 243-250, 2015

Altered pharmacokinetics of piperacillin in febrile neutropenic patients with hematological malignancy. Antimicrobial Agents and ChemoTherapy 58(6): 3533-3537, 2014

Trends in antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infections in the USA, Canada and Latin America. International Journal of Antimicrobial Agents 13(4): 257-271, 2000

Optimal Trough Concentration of Teicoplanin in Febrile Neutropenic Patients with Hematological Malignancy. ChemoTherapy 63(1): 29-34, 2017

Preemptive Antifungal Therapy for Febrile Neutropenic Hematological Malignancy Patients in China. Medical Science Monitor 22(): 4226-4232, 2016

Prevalence and Antimicrobial Resistance of Microbes Causing Bloodstream Infections in Unguja, Zanzibar. Plos One 10(12): E0145632-E0145632, 2016

Increasing Antimicrobial Resistance Monitored in Surveillance Analysis of Blood Stream Infections in Febrile Neutropenic Pediatric Oncology Patients. Asian Pacific Journal of Cancer Prevention 16(14): 5691-5695, 2016

Ceftazidime plus mezlocillin as initial antibiotic therapy in febrile neutropenic patients with hematological malignancy. Journal of Antimicrobial Chemotherapy 15(3): 353-364, 1985